{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:54:48Z","timestamp":1781621688303,"version":"3.54.5"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,16]]},"DOI":"10.7759\/cureus.110964","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:45:51Z","timestamp":1781621151000},"source":"Crossref","is-referenced-by-count":0,"title":["Pseudohypoparathyroidism Type 1A in an Omani Family Demonstrating Phenotypic Heterogeneity and Progressive Biochemical Changes"],"prefix":"10.7759","author":[{"given":"Taher A","family":"Al Shabibi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Al Badi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa","family":"Fadle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0b013e32835a255c","article-title":"An update on the clinical and molecular characteristics of pseudohypoparathyroidism","volume":"19","author":"Levine MA","year":"2012","unstructured":"Levine MA. An update on the clinical and molecular characteristics of pseudohypoparathyroidism. Curr Opin Endocrinol Diabetes Obes. 2012, 19:443-51. 10.1097\/MED.0b013e32835a255c","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000355384","article-title":"The GNAS complex locus and human diseases associated with loss-of-function mutations or epimutations within this imprinted gene","volume":"80","author":"Turan S","year":"2013","unstructured":"Turan S, Bastepe M. The GNAS complex locus and human diseases associated with loss-of-function mutations or epimutations within this imprinted gene. Horm Res Paediatr. 2013, 80:229-41. 10.1159\/000355384","journal-title":"Horm Res Paediatr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-018-0042-0","article-title":"Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement","volume":"14","author":"Mantovani G","year":"2018","unstructured":"Mantovani G, Bastepe M, Monk D, et al.. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement. Nat Rev Endocrinol. 2018, 14:476-500. 10.1038\/s41574-018-0042-0","journal-title":"Nat Rev Endocrinol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2287","article-title":"Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy","volume":"92","author":"de Nanclares GP","year":"2007","unstructured":"de Nanclares GP, Fern\u00e1ndez-Rebollo E, Santin I, et al.. Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy. J Clin Endocrinol Metab. 2007, 92:2370-3. 10.1210\/jc.2006-2287","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/TACG.S51064","article-title":"Progressive osseous heteroplasia: diagnosis, treatment, and prognosis","volume":"8","author":"Pignolo RJ","year":"2015","unstructured":"Pignolo RJ, Ramaswamy G, Fong JT, Shore EM, Kaplan FS. Progressive osseous heteroplasia: diagnosis, treatment, and prognosis. Appl Clin Genet. 2015, 8:37-48. 10.2147\/TACG.S51064","journal-title":"Appl Clin Genet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-024-04761-8","article-title":"Identification of a novel GNAS mutation in a family with\u00a0pseudohypoparathyroidism type 1A","volume":"24","author":"Sippelli F","year":"2024","unstructured":"Sippelli F, Briuglia S, Ferraloro C, et al.. Identification of a novel GNAS mutation in a family with\u00a0pseudohypoparathyroidism type 1A. BMC Pediatr. 2024, 24:271. 10.1186\/s12887-024-04761-8","journal-title":"BMC Pediatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2006.09.001","article-title":"Mutations in the Gs alpha gene causing hormone resistance","volume":"20","author":"Mantovani G","year":"2006","unstructured":"Mantovani G, Spada A. Mutations in the Gs alpha gene causing hormone resistance. Best Pract Res Clin Endocrinol Metab. 2006, 20:501-13. 10.1016\/j.beem.2006.09.001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030028","article-title":"Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance","volume":"88","author":"Germain-Lee EL","year":"2003","unstructured":"Germain-Lee EL, Groman J, Crane JL, Jan de Beur SM, Levine MA. Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance. J Clin Endocrinol Metab. 2003, 88:4059-69. 10.1210\/jc.2003-030028","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvad142","article-title":"Genotype-phenotype correlations in pseudohypoparathyroidism type 1a patients: a systemic review","volume":"189","author":"Jiang S","year":"2023","unstructured":"Jiang S, Yang Y, Song A, et al.. Genotype-phenotype correlations in pseudohypoparathyroidism type 1a patients: a systemic review. Eur J Endocrinol. 2023, 189:S103-11. 10.1093\/ejendo\/lvad142","journal-title":"Eur J Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.03025.x","article-title":"Cognitive impairment is prevalent in pseudohypoparathyroidism type Ia, but not in pseudopseudohypoparathyroidism: possible cerebral imprinting of Gsalpha","volume":"68","author":"Mouallem M","year":"2008","unstructured":"Mouallem M, Shaharabany M, Weintrob N, et al.. Cognitive impairment is prevalent in pseudohypoparathyroidism type Ia, but not in pseudopseudohypoparathyroidism: possible cerebral imprinting of Gsalpha. Clin Endocrinol (Oxf). 2008, 68:233-9. 10.1111\/j.1365-2265.2007.03025.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20252056","article-title":"Pseudohypoparathyroidism type 1A and Albright hereditary osteodystrophy: a comprehensive review of molecular pathogenesis, clinical manifestations, and therapeutic approaches","volume":"13","author":"G\u00e1lvez GL","year":"2025","unstructured":"G\u00e1lvez GL, Roblero JE. Pseudohypoparathyroidism type 1A and Albright hereditary osteodystrophy: a comprehensive review of molecular pathogenesis, clinical manifestations, and therapeutic approaches. Int J Res Med Sci. 2025, 13:3097-102. 10.18203\/2320-6012.ijrms20252056","journal-title":"Int J Res Med Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/498709-pseudohypoparathyroidism-type-1a-in-an-omani-family-demonstrating-phenotypic-heterogeneity-and-progressive-biochemical-changes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:45:52Z","timestamp":1781621152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/498709-pseudohypoparathyroidism-type-1a-in-an-omani-family-demonstrating-phenotypic-heterogeneity-and-progressive-biochemical-changes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.110964","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,16]]}}}